β-locus, early CD4 -/CD8 -double negative (DN) thymic T-cells undergo a process termed 'β-selection' that allows the preferential expansion of cells with a functional TCR β-chain. This process leads to the formation of a rapidly cycling subset of DN cells that subsequently develop into CD4 ϩ /CD8 ϩ double positive (DP) cells. Using transgenic mice that constitutively express the zinc finger protein Gfi-1 and the serine/threonine kinase Pim-1, we found that the levels of both proteins are important for the correct development of DP cells from DN precursors at the stage where 'β-selection' occurs. Analysis of the CD25 ϩ /CD44 -,lo DN subpopulation from these animals revealed that Gfi-1 inhibits and Pim-1 promotes the development of larger β-selected cycling cells ('L subset') from smaller resting cells ('E subset') within this subpopulation. We conclude from our data that both proteins, Pim-1 and Gfi-1, participate in the regulation of β-selection-associated pre-T-cell differentiation in opposite directions and that the ratio of both proteins is important for pre-T-cells to pass the 'E' to 'L' transition correctly during β-selection.
Introduction
T-cells develop from poorly defined precursor cells that infiltrate the thymus from the bone marrow and undergo a series of successive phenotypic transitions that are accompanied by several selection steps, the appearance of specific surface markers and DNA rearrangements of the antigen receptor loci (for a review see Fehling and von Boehmer, 1997) . The most mature TCR α/β ϩ CD4 ϩ and TCR α/β ϩ CD8 ϩ cells (single positive cells, SP) emerge by a process called 'positive selection' from a pool of CD4 ϩ /CD8 ϩ double positive (DP) cells that constitute the major part of the thymus (reviewed in Benoist and Mathis, 1997) . DP cells develop from the CD4 -/CD8 -double negative (DN) population that consists of bone marrowderived precursor cells. These precursors undergo several differentiation and proliferative expansion steps regulated by members of the haematopoietin family of cytokines, particularly interleukin-7 (IL-7) (Murray et al., 1989; Peschon et al., 1994; von Freeden-Jeffrey et al., 1995 Maraskovsky et al., 1997) and the signalling through the pre-T-cell receptor (TCR) complex (Groettrup and von Boehmer, 1993; Fehling et al., 1995) to give rise to CD4 ϩ /CD8 ϩ DP cells. According to their differential expression of the surface molecules CD25 (IL-2 receptor α chain) and CD44 (Pgp-1), immature DN cells can be subdivided into four subpopulations (Pearse et al., 1989; . The two major DN subpopulations consist of CD25 ϩ /CD44 -,lo cells that give rise to CD25 -/CD44 -,lo cells which then quickly upregulate CD4 and CD8 and constitute the DP population. The rearrangement of the TCR β-chain genes takes place in cells of the CD25 ϩ /CD44 -,lo DN population. DP cells and CD25 -/CD44 -,lo DN cells emerging from this pool express functional TCR β-chains and are termed 'β-selected' (Mallick et al., 1993; Dudley et al., 1994) . The process of β-selection is restricted to the CD25 ϩ / CD44 -,lo DN cells and appears to be governed by the assembly of a TCR β-chain, a pTα molecule and CD3 (Fehling and von Boehmer, 1997) . During β-selection, CD25 ϩ /CD44 -DN cells that productively rearrange their TCR β locus and are able to form a pre-TCR complex start to proliferate and enter the next developmental stage; they downregulate CD25 expression and start to upregulate CD4 and CD8. Cells from the CD25 ϩ /CD44 -,lo DN population that fail to rearrange both TCR β alleles productively remain quiescent and die unless they have the potential to become γ/δ cells. A closer analysis of the CD25 ϩ /CD44 -,lo DN cells revealed that this population can be divided further into two subsets: one that contains larger, cycling cells (~15%, termed 'L' cells) with a high proportion of in-frame β-rearrangements and a second subset that represents the major pre-selected population. These cells are termed 'E' cells for 'expected size' and are smaller than the 'L' cells. They are resting cells without an enrichment of in-frame β-rearrangements and represent~85% of the whole CD25 ϩ /CD44 -,lo DN population (Hoffmann et al., 1996) .
The Gfi-1 zinc finger protein is expressed at readily detectable levels almost exclusively in thymocytes, but its role in pre-T-cell development has not been investigated so far. The gfi-1 gene was first discovered as an integration site for Moloney murine leukaemia virus (MoMuLV) in virally infected cells that were selected for IL-2 independence (Gilks et al., 1993) . Other studies involving MoMuLV-infected transgenic mice already carrying the trans-oncogenes pim-1 and L-myc in their germline showed that the gfi-1 gene is a frequent target for the integration of proviral DNA and is most likely involved in the accelerated progression of lymphoid malignancies in MoMuLV-infected lymphoid cells. These findings provided evidence that Gfi-1 can act synergistically at least in the process of lymphomagenesis with Myc, a helixloop-helix zinc finger (HLH-LZ) transcription factor, and Pim-1, a cytoplasmic serine/threonine kinase Zörnig et al., 1996; Scheijen et al., 1997) . The pim-1 gene was itself first identified as a MoMuLV proviral insertion site, and studies in pim-1 transgenic mice demonstrated a low oncogenic potential for Pim-1 (Selten et al., 1985; van Lohuizen et al., 1989) . Biochemical studies suggested that Gfi-1 functions as a transcriptional repressor that mediates its activity by sequence-specific DNA binding in a position-independent manner (Grimes et al., 1996a; Zweidler-McKay et al., 1996) . Although the biological role of Gfi-1 remains to be clarified, several in vitro studies indicated that a constitutive expression can relieve peripheral mature T-cells from a requirement for IL-2 to overcome a G 1 arrest (Grimes et al., 1996a) or, in general, could help to sustain cell proliferation of IL-2 dependent cells in the absence of the cytokine . Surprisingly, Gfi-1 expression is highest in thymocytes (Gilks et al., 1993) where potential signalling via the IL-2 receptor is restricted to the more mature cells that are programmed to leave the thymus to constitute the peripheral immune response.
Experimental results that could shed some light on the role of Gfi-1 in pre-T-cell development in the thymus do not exist at present. Similarly, Pim-1 is expressed in thymic pre-T-cells and its function in pre-T-cell development is not clear either, but MoMuLV infection experiments provided strong evidence that Gfi-1 and Pim-1 cooperate efficiently in T-cell tumorigenesis (see above). This suggests that both proteins are acting in complementary signal transduction pathways that have not yet been identified. Therefore, both proteins are likely to be of considerable interest with regard to a potential role in T-cell differentiation. To be able to gain first insight into the functions of Gfi-1 and Pim-1 in T-cell development and into the nature of their synergistic effects, we analysed gain-of-function mouse mutants that overexpress either Pim-1 or Gfi-1 specifically in T-cells. Analysis of these mouse models showed that high levels of Gfi-1 can inhibit the development of DP thymic T-cells from DN precursors. More precise inspection of the DN subpopulations revealed that the β-selection-associated development of larger cycling L cells from smaller resting E cells within the CD25 ϩ / CD44 -,lo subset was disturbed by Gfi-1, suggesting that Gfi-1 interferes directly with β-selection-associated processes. In contrast, we find that high levels of Pim-1 can promote pre-T-cell development through β-selection and that Pim-1 can relieve the Gfi-1-imposed block in Gfi-1/ Pim-1 double transgenic mice. We propose a model in which Gfi-1 and Pim-1 can regulate the process of β-selection and in particular the E to L cell transition within the CD25 ϩ /CD44 -,lo DN pre-T-cell subset in opposite directions. Our findings infer that both proteins are likely candidates for factors that participate in the regulation of β-selection at a critical point in pre-T-cell differentiation.
Results
Thymic cellularity is reduced in mice overexpressing an lck-driven gfi-1 transgene In order to investigate a possible function of Gfi-1 in T-cell development, we generated transgenic mice that 5350 constitutively express the gfi-1 gene at a higher than endogenous level in the thymus. The murine gfi-1 cDNA was placed between the proximal lck promoter and genomic sequences derived from the human growth hormone (hGH) gene ( Figure 1A ). This construct had been used successfully in earlier experiments . The portion of the construct consisting of the lck promoter, the gfi-1 cDNA and the hGH 3Ј-untranslated region ( Figure 1A ) was microinjected into fertilized oocytes according to standard procedures (see Materials and methods) and several founder animals were obtained. Two founders were chosen to establish transgenic lines by continuous backcrossing with C57/Bl6 animals (lines lck-gfi-1 124 and lck-gfi-1 223). Compared with wild-type animals, mice of both lck-gfi-1 transgenic lines expressed the gfi-1 transgene at elevated levels in the thymus; line 223 at slightly higher protein levels than line 124 ( Figure  1A ). The size and cellularity of the thymus were found to be reduced drastically in animals of both lck-gfi-1 transgenic lines. Cell numbers dropped to~5-20% of normal control littermates ( Figure 1B) . Accordingly, the size of transgenic thymi was significantly smaller but thymic architecture per se was not significantly altered (Figure 1C and D) . The boundaries between thymic cortex and medulla, clearly visible in the normal control, are less pronounced in some areas but still present in thymi from transgenic mice ( Figure 1C and D) . Forced co-expression of the cytoplasmic protein kinase Pim-1 by crossing Eμ pim-1 transgenic mice that express the Pim-1 serine/ threonine kinase in both T-and B-lymphoid compartments (van Lohuizen et al., 1989) with lck-gfi-1 animals could partially restore thymic cellularity in lck-gfi-1 transgenic mice ( Figure 1B ). These findings suggested that overexpression of Gfi-1 impairs normal thymopoiesis and that Pim-1 can to some extent antagonize this activity of Gfi-1.
Differentiation from DN to DP cells is inhibited by high levels of Gfi-1 but can be rescued by co-expression of Pim-1 To identify the differentiation status and thereby the mechanism responsible for the observed loss in thymic cellularity in lck-gfi-1 transgenics, we analysed the frequencies of CD4 and CD8 subsets by flow cytometry. Although all CD4/CD8 thymocyte subsets are present, both transgenic lines displayed drastic alterations in relative percentages and in absolute cell numbers of the different CD4/CD8 subpopulations (Figure 2A, D and E) . In particular, a significant reduction in absolute cell numbers of the SP and the DP subsets was observed ( Figure 2E ), whereas the absolute cell numbers of the DN population remained largely unchanged compared with non-transgenic littermates ( Figure 2E ). In all cases, the transgenic line with the higher level of transgene expression (lck-gfi-1 223) consistently had a more profound phenotype (Figure 2A) .
One possible reason for the apparent loss of CD4 ϩ / CD8 ϩ DP cells could be that high level Gfi-1 expression renders these cells more susceptible to programmed cell death. However, thymocytes explanted from lck-gfi-1 mice were no more prone to cell death than their counterparts from normal littermates when left untreated in medium or when apoptosis was induced with DNA-damaging agents or steroids (data not shown). It has been reported that Gfi-1 directly represses the expression of the Bax and Bak Total number of cells per thymus for non-transgenic control animals (n ϭ 10) and for transgenic animals from the lines lck-gfi-1 124 (n ϭ 6) and lck-gfi-1 223 (n ϭ 7), and from doubly transgenic mice (n ϭ 4) resulting from cross-breeding of the lines Eμ pim-1 (van Lohuizen et al., 1989; Zörnig et al., 1996) and lck-gfi-1 124. All animals were 4-8 weeks old. (C and D) H/E staining of the histological sections demonstrates the size reduction of the transgenic thymus compared with a normal thymus. Shown are photomicrographs of stained histological sections through thymi from a normal control animal (C) and a lck-gfi-1 transgenic mouse (D) representative of several individual animals of both transgenic lines (enlargement was 320-fold).
proteins (Grimes et al., 1996b) . However, no significant changes in the RNA expression levels of Bcl-2 family members, Bax, Bak, Bcl-x or Bcl-2, could be detected in thymi from lck-gfi-1 transgenic mice (data not shown), indicating that the observed loss of DP cells in lck-gfi-1 animals is not due to a higher susceptibility of these cells to undergo cell death. To rule out conclusively that apoptosis is responsible for the loss of DP cells, we crossed the lck-gfi-1 transgenic mice of both lines (124 and 223) to animals that express the Eμ bcl-2 transgene that has been shown previously to be active and expressed in B-and T-lymphoid cells and in particular to be able to rescue DP cells from apoptosis induced by a variety of stimuli (Sentman et al., 1991) . However, double lck-gfi-1/ Eμ bcl-2 transgenics do not show an altered phenotype compared with single lck-gfi-1 transgenics, i.e. a similar degree of DP cell loss was observed in gfi-1/bcl-2 double transgenics ( Figure 2B ). This inability of bcl-2 to rescue the phenotype seen in lck-gfi-1 mice clearly confirmed that the loss of cellularity and in particular the loss of DP cells seen in lck-gfi-1 mice is not due to programmed cell death.
In a subsequent experiment, we analysed the double transgenic mice that resulted from a cross between lckgfi-1 transgenics from the line 124 and Eμ pim-1 animals. In contrast to the gfi-1/bcl-2 mice, we observed that the loss of DP and SP thymocyte subpopulations was indeed restored to almost normal numbers in double pim-1/gfi-1 transgenics ( Figure 2C ), suggesting that Pim-1 is able to counteract the effect of Gfi-1 overexpression on thymic pre-T-cell subsets. One consequence of this combination of Pim-1 and Gfi-1 expression was the restoration of normal numbers of CD4/CD8 DP cells (see Figure 2 ) but also the rapid development of thymic lymphomas in double transgenic mice (Schmidt et al., 1998) . When the lck-gfi-1 line 223 was used for crossings into the Pim-1 transgenics, the synergistic effect of the combination of Pim-1 and Gfi-1 was so strong that no tumour-free animals were obtained for analysis at 4-6 weeks of age (not shown).
V(D)J recombination or lineage decisions do not appear to be affected by high levels of Gfi-1
Examination of the expression of TCR α/β, TCR γ/δ, CD3 and CD25 by flow cytometry showed that both types 
Relative percentages of cells that fall into the four CD4/CD8 subpopulations are shown for both lck-gfi-1 lines, for double transgenic Eμ-pim/lck gfi-1 124 animals as well as for age-matched littermate controls. Shown are average values with standard deviations for several mice representing the two different transgenic lines lck-gfi-1 124 (n ϭ 7) and lck-gfi-1 223 (n ϭ 10), normal control littermates (n ϭ 9) or Eμ pim-1/lck-gfi-1 124 double transgenics (n ϭ 6). (E) Absolute numbers of cells of each CD4/CD8 subpopulation were counted from several 4-to 8-week-old mice of the lck-gfi-1 line 124 (n ϭ 4), the lck-gfi-1 line 223 (n ϭ 6), double Eμ pim-1/lck-gfi-1 124 mice and normal control littermates (n ϭ 8) and are shown as average values with standard deviation.
of TCRs and CD3 molecules as well as the IL-2 receptor α-chain (CD25) are expressed on thymocytes of lck-gfi-1 transgenics, including the major subtypes of TCR β-and α-chains (Vα8 subtype) ( Figure 3 ). However, the relative numbers of TCR γ/δ-bearing cells as well as the relative numbers of CD25 ϩ and CD3 hi cells are altered in thymocytes from both lck-gfi-1 transgenics lines compared with normal control cells ( Figure 3A and B), which is very probably due to the higher relative proportion of CD4 -/ CD8 -DN cells in transgenic thymi (see above; Figure 2 ). Absolute numbers of TCR α/β cells were drastically reduced in the transgenic mice down to 10% of control levels ( Figure 3C ), as was expected considering the loss of DP cells in the lck-gfi-1 transgenics. Also, the absolute number of TCR γ/δ-bearing cells was reduced in lck-gfi-1 animals albeit only to~50% of the levels in non-transgenic controls ( Figure 3D ). The findings further confirm the notion that Gfi-1 overexpression blocks the development 5352 of DP from DN precursors, but demonstrate that this is very unlikely to be due to an altered V(D)J recombination programme, TCR assembly or CD3 expression. Our results rather suggest that high Gfi-1 levels mainly block the replenishment of the thymus with TCR α/β DP and SP cells by inhibiting differentiation of DP cells from the DN precursor pool.
Gfi-1 and Pim-1 overexpression can influence the frequencies and proliferation of CD4 -/CD8 -(DN) subpopulations in the thymus Next, we tested the effect of Gfi-1 and Pim-1 overexpression on the different subsets within the DN subpopulation. The analysis of the expression of CD25 had already shown that the relative number of cells bearing this surface marker was increased in the lck-gfi-1 transgenic mice ( Figure 3A) . The DN thymocyte subpopulation can be subdivided further into several cellular subsets according to the expression of CD25 and CD44 surface markers. As the absolute number of DN cells is not significantly altered in lck-gfi-1 transgenics compared with normal control mice ( Figure 2C ), the CD25/CD44-expressing subpopulations could be compared directly between transgenic and nontransgenic mice. Therefore, we prepared DN cells of lckgfi-1 and control animals by depleting them of CD4 and CD8 positive cells with antibody-coupled magnetic beads. The depleted cells were first checked by flow cytometry to be Ͼ99% CD4 -/CD8 -and then stained for CD25 and CD44 surface markers. The results depicted in Figure 4A 5353 illustrate that expression of the gfi-1 transgene correlated with a strong increase of CD25 ϩ /CD44 -,lo cells (75 and 83% for gate R1) at the expense of CD25 -/CD44 -and CD25 -/CD44 ϩ cells within the DN population in both transgenic mouse lines compared with values obtained from normal controls (54% for gate R1). This suggested that overexpression of Gfi-1 can provoke a developmental block in pre-T-cell differentiation at transition from CD25 ϩ /CD44 -,lo cells to CD25 -/CD44 -,lo cells, leading to a situation where almost all cells in the DN population are of the CD25 ϩ /CD44 -,lo type.
By contrast, in Eμ pim-1 transgenics, the relative numbers for the CD25 ϩ /CD44 -,lo cells dropped to 28% compared with normal controls (54% for gate R1; Figure 4A ). Given that DN to DP transition is not disturbed in Eμ pim-1 mice, this could indicate that high levels of Pim-1 can promote the development of CD25 ϩ /CD44 -,lo pre-T-cells towards CD25 -/CD44 -,lo cells. Forced coexpression of a Gfi-1 transgene in double Pim-1/Gfi-1 transgenics did not alter this low percentage of CD25 ϩ / CD44 -,lo cells (29%; Figure 4A ), indicating that the presence and expression of Pim-1 can overrule the effect of the Gfi-1 transgene. This is in agreement with the finding that the loss of CD4 ϩ /CD8 ϩ DP cell numbers seen in lck-gfi-1 mice is restored in pim-1/gfi-1 double transgenic mice. However, it also suggests that high level expression of Pim-1 and of Gfi-1 disturbs pre-T-cell differentiation. We also observed that in Eμ pim-1 transgenics the CD25 -/ CD44 -,lo DN cell population is underrepresented in comparison with non-transgenic mice ( Figure 4A ). Given that in Eμ pim-1 transgenics a more rapid transition from the DN to the DP stage occurs, this could be interpreted as the result of a more rapid formation of DP cells from CD25 -/ CD44 -,lo DN cells leading to a smaller size of this particular DN subset.
To measure a potential influence of high levels of Gfi-1 and Pim-1 on cell cycle progression of CD25 ϩ /CD44 -,lo pre-T-cells undergoing β-selection, DN cells were prepared, stained with the DNA dye Hoechst 33382 as well as for CD25 and CD44 surface markers and then gated as described in Figure 4A . In both transgenic lines, Gfi-1 alone appeared to arrest CD25 ϩ /CD44 -,lo cells in the G 1 / G 0 phase of the cell cycle ( Figure 4B ), pointing to an inhibitory effect of Gfi-1 on cell cycle progression. Results obtained with Eμ pim-1 mice showed that high levels of Pim-1 alone promoted cell cycle progression in CD25 ϩ / CD44 -,lo cells evidenced by almost 2-fold more cells in S/G 2 /M phase in transgenics compared with normal controls ( Figure 4B ). Co-expression of both Pim-1 and Gfi-1 in double transgenic animals restored a normal proliferation rate in CD25 ϩ /CD44 -,lo DN cells ( Figure 4B ). The findings suggested that elevated levels of Gfi-1 negatively affects and Pim-1 positively affects cell cycle progression in CD25 ϩ /CD44 -,lo DN cells.
Gfi-1 and Pim-1 have antagonistic effects on the transition from E to L cells during β-selection During β-selection, proliferation of DN thymocyte subsets and in particular the CD25 ϩ /CD44 -,lo DN cells occurs upon pre-TCR-mediated signaling in the L subset of the CD25 ϩ /CD44 -,lo DN subpopulation. To obtain a more precise picture and a possible explanation for why CD25 ϩ / CD44 -,lo cells in lck-gfi-1 transgenic mice proliferate at a slower rate as seen in Figure 4 , we gated the CD25 ϩ / CD44 -,lo DN subset on CD4/CD8-depleted cells as described in Figure 4A (gate R1) and analysed their size by analysing cell counts against forward scatter. The boundary between E and L type cells according to their size was done as described (Hoffmann et al., 1996;  Figure  5A , dashed line) and by comparing them with CD25 ϩ / CD44 -,lo DN pre-T-cells from Rag-2-deficient mice that only have E type cells (not shown). We found that the relative proportions of E-type smaller cells versus L-type cells within the CD25 ϩ /CD44 -,lo DN subpopulation were drastically altered by high levels of Gfi-1 (Figure 5 ). In both lines of gfi-1 transgenic mice, the CD25 ϩ /CD44 -,lo DN L-subset is almost non-existent or significantly reduced (4-5% versus 15% in normal mice; Figure 5A ) and cells of the E-type subset dominate this population. As E cells are arrested in G 1 /G 0 and L cells proliferate at a very high rate (Hoffmann et al., 1996; Figure 6 ), the latter account for the cells in S/G 2 /M phase seen in the histograms of CD25 ϩ /CD44 -,lo cells depicted in Figure 4B . This clearly explains the lower proliferation rate seen in CD25 ϩ /CD44 -,lo cells derived from lck-gfi-1 transgenic mice. If Gfi-1 blocks the development of L cells from E cells, then a lower proliferation rate of the whole population of CD25 ϩ / CD44 -,lo cells must be the consequence.
Eμ pim-1 mice showed a higher proportion of L-cells than non-transgenic littermates ( Figure 5A ), which is in agreement with the higher rate of cell proliferation observed for the CD25 ϩ /CD44 -,lo subset in Eμ pim-1 mice ( Figure 4B) . Here, the entire CD25 ϩ /CD44 -,lo subset, even the E subset, appeared to consist of larger cells ( Figure  4B ). The overexpression of both Pim-1 and Gfi-1 in lckgfi-1/Eμ pim-1 double transgenic mice restored the relative proportions of E and L cells in the CD25 ϩ /CD44 -,lo DN subpopulation approximately to those found in nontransgenic animals, but not the size of E cells ( Figure  5A ). These findings suggest that an elevated Gfi-1 expression can inhibit and high Pim-1 levels can promote the E to L transition within the CD25 ϩ /CD44 -,lo DN population.
To rule out that the observed effects are due to altered transgene expression in double pim-1/gfi-1 transgenic mice, we analysed extracts from thymi of different wildtype and transgenic mice. The expression of the pim-1 transgene did not affect transgenic Gfi-1 levels neither did Gfi-1 overexpression alter the expression levels of Pim-1 in double transgenic mice compared with the expression level of both transgenes in the respective single transgenic animals ( Figure 5B and C).
Endogenous levels of Gfi-1 and Pim-1 are differentially regulated during pre-T-cell development To be able to correlate the experimental findings in transgenic mice with a physiological function of Gfi-1 and Pim-1 during β-selection-associated pre-T-cell proliferation and development, we analysed the endogenous expression levels of both Gfi-1 and Pim-1 at different stages of pre-T-cell differentiation. Thymocytes from normal C57/Bl6 mice were depleted of CD4-and CD8-expressing cells by antibody-coupled magnetic beads (Dynal), the depleted cells were stained for CD25 and CD44 and were then sorted preparatively into CD25 ϩ / CD44 -, CD25 -/CD44 -cells by fluorescence-activated cell sorting (FACS) according to the gates depicted in Figure  6A . In addition, the CD25 ϩ /CD44 -subpopulation was sorted into the E and L subset according to their size by gating on forward scatter as previously described (Hoffmann et al., 1996) . As an additional control for correct sorting into E and L cells, the separation was done in comparison with thymocytes prepared from Rag-2-deficient mice that only contain the E subset (not shown). Moreover, correct sorting of CD25 ϩ /CD44 -into E and L cells was demonstrated by staining the subsets with propidium iodide. As expected, the E subset contained only 3% of cells in S/G 2 /M phase of the cell cycle whereas the L subset contained 80% cycling cells (Hoffmann et al., 1996 ; Figure 6B) . A further control for correct sorting of Figure 4 . The gated cells were analysed for cell size by forward angle light scattering. The boundary between E and L cells (dashed line) was set according to Hoffman et al. (1996) and by comparing the CD25 ϩ /CD44 -,lo DN cells with the same subset from Rag-2-deficient mice that have only the E subset (not shown). The large sized subset of CD25 ϩ /CD44 -,lo cells (L-type) is underrepresented and almost absent in both lck-gfi-1 transgenic lines (4 and 5%) compared with negative control littermates (15%). In contrast, Eμ pim-1 animals showed significantly more L cells (37%) than normal mice. The loss of L cells in lck-gfi-1 transgenics is reversed in doubly Eμ pim-1/lck-gfi-1 124 animals (25%). Results are representative of several mice: lck-gfi-1 transgenic lines (line 124, n ϭ 5; line 223, n ϭ 8), normal non-transgenic littermates (n ϭ 7), Eμ-pim-1 (n ϭ 6) and Eμ-pim-1/lck-gfi-1 124 (n ϭ 3). (B and C) Expression control by Western blotting of the Pim-1 and Gfi-1 transgenes in double transgenic mice. The expression level of Gfi-1 or Pim-1 is not altered in the presence of the respective second transgene. the CD25 ϩ /CD44 -cells into E and L subset was provided by analysis of these sorted populations by Western blotting on the expression of the G 1 -specific cell cycle inhibitor p27 KIP ( Figure 6C ) that was, as was described (Hoffmann et al., 1996) , found to be present in E cells but downregulated or absent in L cells.
Western analysis of the sorted subsets showed that endogenous Gfi-1 levels are readily detectable at about equal levels in both CD25 ϩ /CD44 -E and L subsets and at lower levels in CD25 -/CD44 -cells ( Figure 6C ). In contrast, endogenous Pim-1 levels are low in E and L type cells but are strongly up-regulated in CD25 -/CD44 -cells to a much higher level than found in CD25 ϩ / CD44 -E and L cells ( Figure 6C ). This demonstrates a differentially regulated expression of both Gfi-1 and Pim-1 during pre-T-cell differentiation and during β-selectionassociated processes. Moreover, the unaltered endogenous expression levels of both Gfi-1 and Pim-1 in E and L cells suggest that the observed effects of both proteins on the E to L transition (see above) are very probably due to changes in the developmental programme of the cells and are less likely to be a consequence of altered cell cycle progression.
Discussion
The precise control of cell proliferation, differentiation and apoptosis is crucial for organ development and, in particular, pre-T-cell development in the thymus. Here, genomic reorganization, positive and negative selection and a number of signal transduction pathways initiating cell death and proliferation have to be coordinated precisely to ensure proper development of a T-cell repertoire that is able to sustain a T-cell-dependent immune response in (Hoffmann et al., 1996) . Whereas E cells are arrested in G 1 /G 0 , L cells are cycling with Ͼ80% in S/G 2 /M phase. (C) Expression of Gfi-1, Pim-1 and the G 1 -specific cell cycle inhibitor p27 KIP in sorted pre-T-cells. Shown are Western blots of lysates from the following sources: NIH 3T3 cells (no Gfi-1 expression), total thymus (positive control for Gfi-1), sorted CD25 ϩ /CD44 -,lo DN cells, sorted E subset of CD25 ϩ /CD44 -,lo DN cells, sorted L subset of CD25 ϩ /CD44 -,lo DN cells and sorted CD25 -/CD44 -,lo DN cells. In the last lane, extracts of NIH 3T3 cells transfected with a Gfi-1 expression vector were included as an additional control for the identification of the Gfi-1 protein and to show that Gfi-1 itself does not alter the expression levels of Pim-1 or p27 KIP . Equal loading of the gel with protein extracts was controlled by Ponceau staining (not shown). Signal intensities of lanes 3-6 (pre-T-cell sort) can be compared directly because all protein extracts were prepared directly from sorted cells.
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the periphery. Stringent control of proliferation and of developmental progression is of particular importance at the DN stage of pre-T-cell development to ensure that only those cells expand that have a functional TCR β-chain. In this respect, the regulation of developmental processes in the CD25 ϩ /CD44 -,lo DN population is critical for the process of β-selection to prevent 'useless' precursor cells with unproductive TCR β rearrangements from expanding and filling the thymus. Although the process of V(D)J recombination is in some aspects well described (for a review see Willerford et al., 1996) , the factors controlling cell proliferation, differentiation and signalling during the stages of pre-T-cell development when V(D)J recombination takes place remain to be fully elucidated. Here we present data that implicate the zinc finger protein Gfi-1 and the cytoplasmic serine/threonine kinase Pim-1 in the control of β-selection-associated processes that regulate the transition from DN to DP cells in thymic T-cells.
Effects of Gfi-1 levels on thymic cellularity and the DN to DP transition
The phenotype of transgenic mice that overexpress Gfi-1 specifically in thymic T-cells is surprisingly different from what would have been expected based on previous findings where Gfi-1 has been associated with higher proliferation and IL-2 independence or apoptosis (Gilks et al., 1993; Grimes et al., 1996a; Zörnig et al., 1996) . First and most remarkably, the size of the thymus and total thymocyte numbers are very low in lck-gfi-1 transgenics, and the degree of this phenotype correlates with transgenic Gfi-1 expression levels. Elevated susceptibility to cell death has not been observed in lck-gfi-1 mice, and thus does not appear to be responsible for the reduced thymic cellularity. A comparison of the absolute and relative cell numbers showed that the DP and the SP populations are most affected by overexpression of Gfi-1 in transgenic mice, but that the cellularity of the DN subset is not dramatically changed compared with non-transgenic littermates. This suggested that the development of T-cells is disturbed by high levels of Gfi-1 at the transition from DN to DP cells. This effect, provoked by overexpression of Gfi-1, could be explained by a potential activity of Gfi-1 as a repressor of TCR β expression which would lead to a similar phenotype in the gfi-1 transgenics considering that TCR β-deficient mice have a disturbed DN to DP transition (Mombaerts et al., 1992b) . However, this is unlikely since in the lck-gfi-1 transgenic mice the expression level of CD3 or the different TCR chains did not appear to be impaired. Further, TCR α/β cells with a number of Vβ and Vα subtypes as well as TCR γ/δ-bearing cells are clearly present, demonstrating that the process of V(D)J recombination per se is intact and cannot be accountable for the observed phenotype in lck-gfi-1 mice. An alteration of lineage decision early in thymocyte development also seems an unlikely explanation for the observed reduced cellularity in lck-gfi-1 transgenic animals because both TCR α/β and TCR γ/δ cell numbers are reduced in lckgfi-1 transgenic mice. However, lineage commitment may be altered to some degree if one considers that in the lckgfi-1 line TCR α/β cell numbers are reduced to 10% but TCR γ/δ numbers only to~50% of wild-type levels (Washburn et al., 1997) . Therefore, it cannot be completely ruled out that the observed phenotype in Gfi-1 transgenics is due to a disturbed lineage decision.
High Gfi-1 levels block β-selection-associated steps of pre-T-cell development A distinct effect was provoked by Gfi-1 overexpression in transgenic animals: β-selection-associated proliferation that ensures the formation of L cells from E cells within the CD25 ϩ /CD44 -,lo DN population was strongly inhibited by high Gfi-1 levels. This became evident by analysing the size and cell cycle distribution of CD25 ϩ /CD44 -,lo DN cells and the finding that only E cells and almost no L cells are found in lck-gfi-1 transgenic animals. These effects explain very well the general phenotype observed in lck-gfi-1 transgenic mice, namely the reduced numbers of DP and SP cells in transgenic thymus and the loss of thymic cellularity in these mice. Gfi-1 overexpression could either block the proliferation of L cells or inhibit the progression of differentiation from E to L cells, i.e. block a developmental step. If the physiological role of Gfi-1 in these cells was the repression of cell cycle progression, one would expect to see lower endogenous Gfi-1 levels in normal L cells that are heavily cycling compared with normal E cells. However, this is not the case, as demonstrated here in Figure 6C , making it more likely that Gfi-1 functions as a regulator of the size of the CD25 ϩ /CD44 -,lo DN subpopulation and the developmental step that controls E to L transition. Clearly, as demonstrated here, the maintenance of certain Gfi-1 levels appears crucial for the correct developmental progression of pre-T-cells through these steps. Given the differential expression of Gfi-1 in DN subsets, it is conceivable that this zinc finger protein is indeed important for early T-cell differentiation associated with β-selection, although complete proof can only come from mutant mice deficient for Gfi-1.
The finding that co-expression of the serine/threonine kinase Pim-1 can counteract the effect of high Gfi-1 expression levels could suggest that both proteins regulate β-selection-associated E to L transition in opposite directions and that in addition to the level of Gfi-1, the Pim-1 level is also a critical factor in β-selection-associated pre-T-cell development. Furthermore, the analysis of endogenous Pim-1 protein levels demonstrated that its expression is also regulated differentially in the DN subpopulations but, similarly to Gfi-1, it is not altered at the E to L transition, implying that the ratio of Gfi-1 and Pim-1 levels is the critical parameter. Moreover, endogenous levels of Gfi-1 appear to be down-regulated in CD25 -/CD44 -DN cells compared with CD25 ϩ / CD44 -,lo DN cells but, in contrast, Pim-1 levels are low in CD25 ϩ /CD44 -,lo DN cells and are strongly upregulated in the emerging CD25 -/CD44 -DN population. Considering that the regulation of endogenous Gfi-1 and Pim-1 expression occurs in opposite directions in CD25 ϩ and CD25 -DN subsets and the effect that constitutive expression of both proteins has on DN subpopulations, it is conceivable that they take part in the regulation of DN T-cell development not only at the E to L transition but also at the progression from CD25 ϩ to CD25 -cells.
A number of experiments have shown that the presence of a functional TCR β-chain is crucial for the E to L transition during β-selection (Mombaerts et al., 1992a,b; 5357 Shinkai et al., 1992; Hoffmann et al., 1996) . The findings presented here clearly suggest that the relative levels of Gfi-1 and Pim-1 are important for precisely this step, namely the E to L transition, where the presence of a functional TCR β-chain is critical. We have shown that Gfi-1 overexpression does not affect expression of TCR subtypes and apparently does not affect rearrangement of TCR β-chain genes nor their correct expression. This offers the possibility that Gfi-1 and Pim-1 interfere at some point further downstream with pre-TCR-initiated signalling or other events to provoke the observed effects. Experiments in which lck-gfi-1 transgenic mice were crossed with animals that are deficient in the TCR β-specific enhancer and do not express a TCR β-chain (Bouvier et al., 1996) provided the first hint that the effect of Gfi-1 on DN to DP transition is independent of the presence of a TCR β-chain. Mice that are defective for the TCR β enhancer element still show considerable formation of DP cells that are TCR α/β negative. We found that the presence of the lck-gfi-1 transgene in TCR β enhancer-defective mice completely abrogated the formation of these DP cells (T.Schmidt, T. Möröy and P.Ferrier, in preparation) . This suggested that the effect of Gfi-1 on DN to DP transition is independent of the formation of a TCR β-chain and most probably affects signal transduction events downstream of TCR β, possibly the Ras/Raf/MAPK pathway (see below) or other signalling events necessary for the DN to DP transition. In a similar experiment, we have crossed the Eμ pim-1 transgenic mice into Rag-2 -/-mice that are not able to form TCR β-chains or any other TCR chain. These mice (Eμ pim-1/Rag-2 -/-) showed a variable but clear presence of DP cells which must have developed independently of a TCR β-chain in the Rag-2-negative background upon overexpression of Pim-1 (T.Schmidt, T. Möröy and P.Ferrier, in preparation) . This suggested that the effect of Pim-1 on DN to DP transition is also independent of TCR β rearrangements or the presence of a TCR β-chain, and that Pim-1, similarly to Gfi-1, affects signal transduction events downstream of TCR β or other signalling events necessary for the DN to DP transition. Both experiments indicate that the differentiaton process of DN cells to DP cells is not regulated entirely by receptor complexes that contain a TCR β-chain but that additional mechanisms must exist that may well be regulated conversely by Gfi-1 and Pim-1.
To date, little is known about downstream factors that mediate pre-TCR signalling. Clearly, as the Ras/Raf/ MAPK pathway is considered to be a strong candidate signalling pathway that is responsible for the production of L cells during β-selection Swat et al., 1996) , one would have to propose that Gfi-1 or Pim-1 modulate signalling through this pathway. One argument for this view is clearly circumstantial, but nevertheless compelling. Rag-2-or Rag-1-deficient mice show a block in the DN to DP transition because they lack a functional TCR β-chain and their pre-T-cells cannot undergo β-selection and the associated proliferative steps; i.e. they cannot produce a CD25 ϩ /CD44 -,lo DN L subset (Mombaerts et al., 1992a,b; Shinkai et al., 1992; Hoffmann et al., 1996) . In this respect, Rag -/-mice are similar to the lck-gfi-1 mice described here because the block of T-cell development in these animals occurs at the same point as in lck-gfi-1 mice, namely where β-selection takes place and where signalling from a pre-TCR is thought to promote the development of L cells from E cells. Further, it has been shown that expression of activated Ha-ras can restore the formation of DP cells in Rag-2 -/-mice and that MAPK as a downstream target of Ras is responsible for the development of DN cells to DP cells , making it very likely that the Ras/Raf/MAPK pathway represents one of the pre-TCR-initiated signals necessary for β-selection-associated proliferation and differentiation, or at least can mimick it. Because Gfi-1 overexpression provokes a developmental block at exactly the same position as in Rag-deficient animals, the data presented here infer that high levels of Gfi-1 can interfere with pre-TCR signalling. Therefore, it is not unlikely that Gfi-1 is able to modulate Ras/Raf/ MAPK-initiated signalling. Interestingly, it is now well established that IL-2 is able to induce signalling through Ras/Raf/MAPK as well (Satoh et al., 1991; Graves et al., 1992) . Interference by Gfi-1 in Ras/Raf/MAPK signalling potentially could integrate the findings described here and the known effects of Gfi-1 with regard to IL-2 independence (Gilks et al., 1993; Zörnig et al., 1996) . Although this would represent an attractive possibility for a framework in which Gfi-1 or Pim-1 could act, direct evidence for such an activity has to await additional experiments and in particular the elucidation of the molecular downstream targets of Gfi-1 and Pim-1.
Materials and methods

Generation of transgenic mice
A schematic representation of the construct used to generate lck-gfi-1 transgenic mice is given in Figure 2A . The construct was obtained by inserting a 2 kb HincII fragment containing the murine gfi-1 cDNA into the plck vector. The vector contained the proximal lck promoter and the genomic sequence of the hGH gene in a Bluescript background. The construct was freed from background sequences, purified and injected into fertilized mouse oocytes essentially as described (Hogan et al., 1994) . The fertilized mouse oocytes were derived from matings between (C57Bl/6ϫC3H) F1 mice. Successful integration of the injected DNA was monitored by Southern analysis of tail tip DNA as described (Hogan et al., 1994) . All transgenic mouse lines were maintained by breeding the obtained founders for three or more generations with inbred C57Bl/6 animals. Crossings with Eμ pim-1 transgenics were performed as previously described . Preparation of genomic DNA from tail tips and DNA blotting procedures were performed as described elsewhere (Sambrook et al., 1989; Hogan et al., 1994) . The gfi-1 probe was a 2 kb HincII cDNA fragment . Preparation of RNA and Northern blotting was performed according to described procedures (Sambrook et al., 1989) .
Anti-Gfi-1 antibodies and affinity purification A peptide consisting of AS 14-27 of the Gfi-1 protein was synthesized and coupled to keyhole limpet haemocyanin (KLH; Sigma) via glutaraldehyde. Coupling, subsequent immunization and antisera preparation from rabbits were carried out as described (Harlow and Lane, 1988 ). Antisera titres were tested by enzyme-linked immunosorbent assay (ELISA) against the Gfi-1 peptide. For recombinant protein expression in bacteria, the entire coding region of Gfi-1 was cloned into the His tag expression vector pQE-30 (Qiagen) by PCR (Vent Polymerase, NEB). His-tagged Gfi-1 was expressed and purified under denaturing conditions according to the manufacturer's instructions (Qiagen). Expression and purification were controlled by imunoblotting with an antibody directed against the RGS-His-tag (Qiagen). Approximately 300 μg of recombinant Gfi-1 protein were subjected to SDS-PAGE and transferred onto a Hybond C ϩ membrane (Amersham). The area of the membrane loaded with recombinant Gfi-1 protein was detected by Ponceau staining, cut out and used for antisera affinity purification. First, the membrane 5358 was blocked with phosphate-buffered saline (PBS), 0.1% Tween-20, 5% skim milk (60 min, all steps at room temperature) and then incubated with antisera (1:50 dilution in PBS, 0.1% Tween-20, 5% skim milk) for 2 h. After washing with PBS/0.1% Tween-20 several times, bound antibody molecules were eluted with 900 μl of 200 mM glycine pH 2.2, 0.5% bovine serum albumin (BSA) (2 min) followed by immediate neutralization of the eluate in 100 μl of 1 M Tris pH 8.0. The eluate was used at a 1:200 dilution in immunoblots. Quality and specificity of the purified antibodies were monitored by immunoblotting with in vitro translated Gfi-1 protein.
Antibody staining procedures and cell cycle analysis
Single cell suspensions were prepared as described (Möröy et al., 1993) at the time of autopsy from spleen, thymus or lymph nodes in PBS supplemented with 0.5% fetal calf serum (FCS) (staining solution). Cells were washed in this solution and incubated on ice for 30 min with antibodies directly conjugated with fluorochromes. Cells were washed twice in staining solution after the incubation and examined with a FACSCALIBUR (Becton-Dickinson). To analyse the DN population from thymus, CD4 and CD8 surface molecules were stained with the respective antibodies labelled with Tri-colour, and FITC-labelled anti-CD25 and PE-labelled anti-CD44. DP cells positive for Tri-colour staining were gated out, and the remaining population was analysed in a two-dimensional plot. Alternatively, CD4 and CD8 cells were depleted by magnetic beads coupled to the respective antibodies. Antibodies against TCR β-or α-chain subtypes or against TCR γ/δ were purchased from Pharmingen; all other antibodies used in FACS analysis were obtained from Medac. For propidium iodide labelling and cell cycle analysis, cells were washed once with cold PBS and fixed with ethanol overnight at 4°C. The cells were again washed and then incubated in 2 μg/ml propidium iodide (Sigma) in PBS/RNase (10 μg/ml) for 15 min. For the cell cycle analysis of DN subsets, thymocytes were depleted of CD4 ϩ and CD8 ϩ cells with magnetic beads (Dynal) and then stained with labelled antibodies against CD25 and CD44. The cells were again washed and then incubated in 2 μg/ml Hoechst 33382 (Sigma) in PBS for 30 min at 37°C. FACS analysis on the gated DN subsets was done by flow cytometry with a UV laser at 424 nm.
Immunoblotting
Extracts from thymi were loaded and separated on SDS-PAGE, transferred onto membranes and the Gfi-1 protein was detected with an antiGfi-1 rabbit antiserum using anti-rabbit Ig coupled to horseradish peroxidase. The enzymatic activity was detected using an ECL kit (Amersham) according to the specifications of the manufacturer. Equal and homogeneous transfer of proteins from the gel to membranes was controlled routinely by Ponceau staining of the membrane. NIH 3T3 cells were seeded on a 6 cm plate and transfected transiently with 8 μg of plasmid with Lipofectamine. After 2 days, cells were harvested in 1 ml of PBS, collected by centrifugation, and lysed in 100 μl of extraction buffer [50 mM HEPES pH 7.8, 20 mM NaF, 1 mM Na orthovanadate, 1 mM Na molybdate, 450 mM NaCl, 0.2 mM EDTA, 25% glycerol, 50 μg aprotinin, 50 μg leupeptin, 0.5 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM dithiothreitol (DTT), 1% NP-40]. The lysate was cleared by centrifugation and the supernatant was separated by electrophoresis and transferred onto a nitrocellulose membrane. Untransfected cells were run as a control. The membrane was blocked overnight in PBS/0.1% Tween-20 with 5% skim milk and then incubated in blocking solution containing the respective antibodies for 2 h at 0.3 μg/ml. Blots were developed with appropriate secondary antibodies and ECL detection reagents (Amersham) as proposed by the manufacturer.
Histology
Thymi were fixed in 4% paraformaldehyde or in Carnoy's solution (60% ethanol, 30% chloroform, 10% acetic acid), embedded in paraffin and sectioned using a cryomicrotome. Sections were stained with haematoxylin/eosin.
